Medicalgorithmics SA stock news
Medicalgorithmics SA (WSE: MDG) has published its 2025 annual financial summary, reporting a 29% year--on--year increase in consolidated revenue to PLN 31.0 million. The company achieved a significant operational milestone by reaching an operating cash break--even in the fourth quarter of 2025, supported by a positive EBITDA of PLN 1.0 million and operating cash flow of PLN 1.8 million. Growth was primarily driven by the U.S. market, which saw a 140% revenue increase to PLN 11.3 million. For the 2026 fiscal year, the company has already secured new agreements with partners in the U.S., Peru, and South Korea, and confirmed a contract to supply 250 PocketECG devices to a Swedish hospital.